annual SGA:
$31.87M+$8.41M(+35.88%)Summary
- As of today (July 6, 2025), EWTX annual SGA is $31.87 million, with the most recent change of +$8.41 million (+35.88%) on December 31, 2024.
- During the last 3 years, EWTX annual SGA has risen by +$20.84 million (+189.01%).
- EWTX annual SGA is now at all-time high.
Performance
EWTX SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly SGA:
$9.20M+$32.00K(+0.35%)Summary
- As of today (July 6, 2025), EWTX quarterly SGA is $9.20 million, with the most recent change of +$32.00 thousand (+0.35%) on March 31, 2025.
- Over the past year, EWTX quarterly SGA has increased by +$2.14 million (+30.36%).
- EWTX quarterly SGA is now at all-time high.
Performance
EWTX quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM SGA:
-$1.44B-$146.09M(-11.28%)Summary
- As of today (July 6, 2025), EWTX TTM SGA is -$1.44 billion, with the most recent change of -$146.09 million (-11.28%) on March 31, 2025.
- Over the past year, EWTX TTM SGA has dropped by -$1.47 billion (-5940.66%).
- EWTX TTM SGA is now -4121.89% below its all-time high of -$34.15 million.
Performance
EWTX TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Selling, general & administrative expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
EWTX Selling, general & administrative expenses Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +35.9% | +30.4% | -5940.7% |
3 y3 years | +189.0% | +148.6% | -10000.0% |
5 y5 years | +2351.2% | +3174.7% | -10000.0% |
EWTX Selling, general & administrative expenses Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | at high | +189.0% | at high | +125.0% | -323.4% | at low |
5 y | 5-year | at high | +2351.2% | at high | +2793.7% | -4121.9% | at low |
alltime | all time | at high | +2351.2% | at high | +3174.7% | -4121.9% | at low |
EWTX Selling, general & administrative expenses History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2025 | - | $9.20M(+0.3%) | $34.01M(+6.7%) |
Dec 2024 | $31.87M(+35.9%) | $9.17M(+11.7%) | $31.87M(+10.4%) |
Sep 2024 | - | $8.21M(+10.5%) | $28.87M(+9.7%) |
Jun 2024 | - | $7.43M(+5.2%) | $26.33M(+6.7%) |
Mar 2024 | - | $7.06M(+14.3%) | $24.68M(+5.2%) |
Dec 2023 | $23.45M(+33.1%) | $6.18M(+9.0%) | $23.45M(+3.1%) |
Sep 2023 | - | $5.67M(-2.0%) | $22.74M(+6.1%) |
Jun 2023 | - | $5.78M(-0.8%) | $21.44M(+8.6%) |
Mar 2023 | - | $5.83M(+6.6%) | $19.75M(+12.1%) |
Dec 2022 | $17.63M | $5.47M(+25.2%) | $17.63M(+10.9%) |
Sep 2022 | - | $4.37M(+6.8%) | $15.89M(+8.0%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Jun 2022 | - | $4.09M(+10.5%) | $14.72M(+11.3%) |
Mar 2022 | - | $3.70M(-0.9%) | $13.23M(+20.0%) |
Dec 2021 | $11.03M(+399.1%) | $3.73M(+16.8%) | $11.03M(+29.8%) |
Sep 2021 | - | $3.20M(+23.0%) | $8.50M(+48.9%) |
Jun 2021 | - | $2.60M(+73.6%) | $5.71M(+66.6%) |
Mar 2021 | - | $1.50M(+24.2%) | $3.42M(+55.0%) |
Dec 2020 | $2.21M(+69.9%) | $1.21M(+197.5%) | $2.21M(+120.0%) |
Sep 2020 | - | $405.00K(+27.4%) | $1.00M(+67.6%) |
Jun 2020 | - | $318.00K(+13.2%) | $599.00K(+113.2%) |
Mar 2020 | - | $281.00K | $281.00K |
Dec 2019 | $1.30M | - | - |
FAQ
- What is Edgewise Therapeutics annual SGA?
- What is the all time high annual SGA for Edgewise Therapeutics?
- What is Edgewise Therapeutics annual SGA year-on-year change?
- What is Edgewise Therapeutics quarterly SGA?
- What is the all time high quarterly SGA for Edgewise Therapeutics?
- What is Edgewise Therapeutics quarterly SGA year-on-year change?
- What is Edgewise Therapeutics TTM SGA?
- What is the all time high TTM SGA for Edgewise Therapeutics?
- What is Edgewise Therapeutics TTM SGA year-on-year change?
What is Edgewise Therapeutics annual SGA?
The current annual SGA of EWTX is $31.87M
What is the all time high annual SGA for Edgewise Therapeutics?
Edgewise Therapeutics all-time high annual SGA is $31.87M
What is Edgewise Therapeutics annual SGA year-on-year change?
Over the past year, EWTX annual SGA has changed by +$8.41M (+35.88%)
What is Edgewise Therapeutics quarterly SGA?
The current quarterly SGA of EWTX is $9.20M
What is the all time high quarterly SGA for Edgewise Therapeutics?
Edgewise Therapeutics all-time high quarterly SGA is $9.20M
What is Edgewise Therapeutics quarterly SGA year-on-year change?
Over the past year, EWTX quarterly SGA has changed by +$2.14M (+30.36%)
What is Edgewise Therapeutics TTM SGA?
The current TTM SGA of EWTX is -$1.44B
What is the all time high TTM SGA for Edgewise Therapeutics?
Edgewise Therapeutics all-time high TTM SGA is -$34.15M
What is Edgewise Therapeutics TTM SGA year-on-year change?
Over the past year, EWTX TTM SGA has changed by -$1.47B (-5940.66%)